|
1
|
Abed AB, Kavvadas P and Chadjichristos CE:
Functional roles of connexins and pannexins in the kidney. Cell Mol
Life Sci. 72:2869–2877. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dantzler WH: Challenges and intriguing
problems in comparative renal physiology. J Exp Biol. 208:587–594.
2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Iglesias P, Bajo MA, Selgas R and Díez JJ:
Thyroid dysfunction and kidney disease: An update. Rev Endocr Metab
Disord. 18:131–144. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mandita A, Timofte D, Balcangiu-Stroescu
AE, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dragos D,
Cosconel CI, Stoicescu SM and Ionescu D: Treatment of high blood
pressure in patients with chronic renal disease. Rev Chim Buchar.
70:993–995. 2019.
|
|
5
|
Young RH and Eble JN: The history of
urologic pathology: An overview. Histopathology. 74:184–212.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Dan Spinu A, Gabriel Bratu O, Cristina
Diaconu C, Maria Alexandra Stanescu A, Bungau S, Fratila O,
Bohiltea R and Liviu Dorel Mischianu D: Botulinum toxin in low
urinary tract disorders-over 30 years of practice (Review). Exp
Ther Med. 20:117–120. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Siew ED and Davenport A: The growth of
acute kidney injury: A rising tide or just closer attention to
detail? Kidney Int. 87:46–61. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Khwaja A: KDIGO clinical practice
guidelines for acute kidney injury. Nephron Clin Pract.
120:C179–C184. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sanz AB, Sanchez-Niño MD, Martin-Cleary C,
Ortiz A and Ramos AM: Progress in the development of animal models
of acute kidney injury and its impact on drug discovery. Expert
Opin Drug Discov. 8:879–895. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Timofte D, Dragoș D, Balcangiu-Stroescu
AE, Tănăsescu MD, Gabriela Bălan D, Răducu L, Tulin A, Stiru O and
Ionescu D: Abdominal aortic calcification in predialysis patients:
Contribution of traditional and uremia-related risk factors. Exp
Ther Med. 20:97–102. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Totan A, Balcangiu-Stroescu AE, Melescanu
Imre M, Miricescu D, Balan DG, Stanescu II, Ionescu D, Timofte D,
Tanasescu MD and Greabu M: XOR-possible correlations with oxidative
stress and inflammation markers in the context of diabetic kidney
disease. Rev Chim Buchar. 70:1396–1398. 2019.
|
|
12
|
Balcangiu-Stroescu AE, Tanasescu MD,
Diaconescu AC, Raducu L, Balan DG, Mihai A, Tanase M, Stanescu II
and Ionescu D: Diabetic nephropathy: A concise assessment of the
causes, risk factors and implications in diabetic patients. Rev
Chim Buchar. 69:3118–3121. 2018.
|
|
13
|
Silva Junior GB, Bentes AC, Daher EF and
Matos SM: Obesity and kidney disease. J Bras Nefrol. 39:65–69.
2017.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
14
|
Balan DG, Tanasescu MD, Diaconescu A,
Raducu L, Mihai A, Tanase M, Stanescu II, Ionescu D and
Balcangiu-Stroescu AE: Nutritional intervention in patients with
diabetic renal disease a brief presentation. Rev Chim Buchar.
69:4078–4082. 2018.
|
|
15
|
Zhang J and Ningning W: Leptin in chronic
kidney disease: A link between hematopoiesis, bone metabolism, and
nutrition. Int Urol Nephrol. 46:1169–1174. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Andrassy KM: Comments on ‘KDIGO 2012
clinical practice guideline for the evaluation and management of
chronic kidney disease’. Kidney Int. 84:622–623. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Levey AS, Eckardt KU, Tsukamoto Y, Levin
A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N and
Eknoyan G: Definition and classification of chronic kidney disease:
A position statement from kidney disease: Improving global outcomes
(KDIGO). Kidney Int. 67:2089–2100. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
KDIGO CKD Work Group. KDIGO 2012 clinical
practice guideline for the evaluation and management of chronic
kidney disease. Kidney Int Suppl. 3:1–150. 2013.
|
|
19
|
Balcangiu-Stroescu AE, Tanasescu MD,
Diaconescu AC, Raducu L, Constantin AM, Balan DG, Ţarmure V and
Ionescu D: Cardiovascular comorbidities, inflammation and serum
albumin levels in a group of hemodialysis patients. Rev Chim
Buchar. 69:926–929. 2018.
|
|
20
|
Timofte D, Ionescu D, Medrihan L, Mandita
A, Rasina A and Damian L: Vascular calcification and bone disease
in hemodialysis patients assessment, association and risk factors.
Nephrol Dial Transplant. 22:325–326. 2007.
|
|
21
|
Craver L, Marco MP, Martínez I, Rue M,
Borràs M, Martín ML, Sarró F, Valdivielso JM and Fernández E:
Mineral metabolism parameters throughout chronic kidney disease
stages 1-5-achievement of K/DOQI target ranges. Nephrol Dial
Transplant. 22:1171–1176. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kovesdy CP, Furth S and Zoccali C: World
Kidney Day Steering Committee. Obesity and kidney disease: Hidden
consequences of the epidemic. Indian J Nephrol. 27:85–92.
2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Timofte D, Mandita A, Balcangiu-Stroescu
AE, Balan D, Raducu L, Tanasescu MD, Diaconescu A, Dorin D,
Cosconel CI and Ionescu D: Hyperuricemia and cardiovascular
diseases-clinical and paraclinical correlations. Rev Chim Buchar.
70:1045–1046. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Popa AR, Vesa CM, Uivarosan D, Jurca CM,
Isvoranu G, Socea B, Stanescu AM, Iancu MA, Scarneciu I and Zaha
DC: Cross sectional study regarding the association between
sweetened beverages intake, fast-food products, body mass index,
fasting blood glucose and blood pressure in the young adults from
north-western Romania. Rev Chim. 70:156–160. 2019.
|
|
25
|
Stanescu AM, Grajdeanu IV, Iancu MA,
Stoian AP, Bratu OG, Socea B, Socea LI and Diaconu CC: Correlation
of oral vitamin D administration with the severity of psoriasis and
the presence of metabolic syndrome. Rev Chim Buchar. 69:1668–1672.
2018.
|
|
26
|
Dan SA, Bratu OG, Marcu DR, Stanciu AE,
Gherghiceanu F, Ionita-Radu F, Bungau S, Stanescu AMA and Mischianu
D: Underactive bladder-an underestimated entity. J Mind Med Sci.
7:23–28. 2020.
|
|
27
|
Nittari G, Scuri S, Petrelli F, Pirillo I,
di Luca NM and Grappasonni I: Fighting obesity in children from
European world health organization member states. Epidemiological
data, medicalsocial aspects, and prevention programs. Clin Ter.
170:e223–e230. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chomba H, Martin HD and Kimywe J:
Prevalence and predictors of obesity among 7- to 17-year-old
schoolchildren in urban arusha, Tanzania. J Nutr Metab.
2019(3106597)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Smitka K and Marešová D: Adipose tissue as
an endocrine organ: An update on pro-inflammatory and
anti-inflammatory microenvironment. Prague Med Rep. 116:87–111.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Maalouf NM, Sakhaee K, Parks JH, Coe FL,
Adams-Huet B and Pak CY: Association of urinary pH with body weight
in nephrolithiasis. Kidney Int. 65:1422–1425. 2004.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Siener R, Glatz S, Nicolay C and Hesse A:
The role of overweight and obesity in calcium oxalate stone
formation. Obes Res. 12:106–113. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tessaro CZ, Ramos CI and Heilberg IP:
Influence of nutritional status, laboratory parameters and dietary
patterns upon urinary acid excretion in calcium stone formers. J
Bras Nefrol. 40:35–43. 2018.PubMed/NCBI View Article : Google Scholar : (In English,
Portuguese).
|
|
33
|
Taylor EN, Stampfer MJ and Curhan GC:
Diabetes mellitus and the risk of nephrolithiasis. Kidney Int.
68:1230–1235. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Poore W, Boyd CJ, Singh NP, Wood K, Gower
B and Dean GA: Obesity and its impact on kidney stone formation.
Rev Urol. 22:17–23. 2020.PubMed/NCBI
|
|
35
|
Toto RD, Greene T, Hebert LA, Hiremath L,
Lea JP, Lewis JB, Pogue V, Sika M and Wang X: AASK Collaborative
Research Group. Relationship between body mass index and
proteinuria in hypertensive nephrosclerosis: Results from the
African American study of kidney disease and hypertension (AASK)
cohort. J Kidney Dis. 56:896–906. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ejerblad E, Fored CM, Lindblad P, Fryzek
J, McLaughlin JK and Nyrén O: Obesity and risk for chronic renal
failure. J Am Soc Nephrol. 17:1695–1702. 2006.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Fox CS, Larson MG, Leip EP, Culleton B,
Wilson PW and Levy D: Predictors of new-onset kidney disease in a
community-based population. JAMA. 291:844–850. 2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Hall ME, do Carmo JM, da Silva AA, Juncos
LA, Wang Z and Hall JE: Obesity, hypertension, and chronic kidney
disease. Int J Nephrol Renovasc Dis. 7:75–88. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sugerman H, Windsor A, Bessos M and Wolfe
L: Intra-abdominal pressure, sagittal abdominal diameter and
obesity comorbidity. J Intern Med. 241:71–79. 1997.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hall JE, Crook ED, Jones DW, Wofford MR
and Dubbert PM: Mechanisms of obesity-associated cardiovascular and
renal disease. Am J Med Sci. 324:127–137. 2002.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Eckel RH, Barouch WW and Ershow AG: Report
of the national heart, lung, and blood institute-national institute
of diabetes and digestive and kidney diseases working group on the
pathophysiology of obesity-associated cardiovascular disease.
Circulation. 105:2923–2928. 2002.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Dwyer TM, Bigler SA, Moore NA, Carroll JF
and Hall JE: The altered structure of renal papillary outflow
tracts in obesity. Ultrastruct Pathol. 24:251–257. 2000.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Dwyer TM, Banks SA, Alonso-Galicia M,
Cockrell K, Carroll JF, Bigler SA and Hall JE: Distribution of
renal medullary hyaluronan in lean and obese rabbits. Kidney Int.
58:721–729. 2000.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chandra A, Neeland IJ, Berry JD, Ayers CR,
Rohatgi A, Das SR, Khera A, McGuire DK, de Lemos JA and Turer AT:
The relationship of body mass and fat distribution with incident
hypertension: Observations from the Dallas heart study. J Am Coll
Cardiol. 64:997–1002. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Pinto-Sietsma SJ, Navis G, Janssen WM, de
Zeeuw D, Gans RO and de Jong PE: PREVEND Study Group. A central
body fat distribution is related to renal function impairment, even
in lean subjects. Am J Kidney Dis. 41:733–741. 2003.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Henegar JR, Bigler SA, Henegar LK, Tyagi
SC and Hall JE: Functional and structural changes in the kidney in
the early stages of obesity. J Am Soc Nephrol. 12:1211–1217.
2001.PubMed/NCBI
|
|
47
|
Rutkowski P, Klassen A, Sebekova K, Bahner
U and Heidland A: Renal disease in obesity: The need for greater
attention. J Ren Nutr. 16:216–223. 2006.PubMed/NCBI View Article : Google Scholar
|
|
48
|
De Jong PE, Verhave JC, Pinto-Sietsma SJ
and Hillege HL: PREVEND study group. Obesity and target organ
damage: The kidney. Int J Obes Relat Metab Disord. 26 (Suppl
4):S21–S24. 2002.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mascali A, Franzese O, Nisticò S, Campia
U, Lauro D, Cardillo C, Di Daniele N and Tesauro M: Obesity and
kidney disease: Beyond the hyperfiltration. Int J Immunopathol
Pharmacol. 29:354–363. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Amann K and Benz K: Structural renal
changes in obesity and diabetes. Semin Nephrol. 33:23–33.
2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kambham N, Markowitz GS, Valeri AM, Lin J
and D'Agati VD: Obesity-related glomerulopathy: An emerging
epidemic. Kidney Int. 59:1498–1509. 2001.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Tsuboi N, Utsunomiya Y, Kanzaki G, Koike
K, Ikegami M, Kawamura T and Hosoya T: Low glomerular density with
glomerulomegaly in obesity-related glomerulopathy. Clin J Am Soc
Nephrol. 7:735–741. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Okabayashi Y, Tsuboi N, Sasaki T, Haruhara
K, Kanzaki G, Koike K, Miyazaki Y, Kawamura T, Ogura M and Yokoo T:
Glomerulopathy associated with moderate obesity. Kidney Int Rep.
1:250–255. 2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Tsuboi N, Utsunomiya Y and Hosoya T:
Obesity-related glomerulopathy and the nephron complement. Nephrol
Dial Transplant. 28 (Suppl 4):iv108–iv113. 2013.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wickman C and Kramer H: Obesity and kidney
disease: Potential mechanisms. Semin Nephrol. 33:14–22.
2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Cassis LA, Police SB, Yiannikouris F and
Thatcher SE: Local adipose tissue renin-angiotensin system. Curr
Hypertens Rep. 10:93–98. 2008.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Marcus Y, Shefer G and Stern N: Adipose
tissue renin-angiotensin-aldosterone system (RAAS) and progression
of insulin resistance. Mol Cell Endocrinol. 378:1–14.
2013.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Cabandugama PK, Gardner MJ and Sowers JR:
The renin angiotensin aldosterone system in obesity and
hypertension: Roles in the cardiorenal metabolic syndrome. Med Clin
North Am. 101:129–137. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Vincent HK and Taylor AG: Biomarkers and
potential mechanisms of obesity-induced oxidant stress in humans.
Int J Obes (Lond). 30:400–418. 2006.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Boustany CM, Bharadwaj K, Daugherty A,
Brown DR, Randall DC and Cassis LA: Activation of the systemic and
adipose renin-angiotensin system in rats with diet-induced obesity
and hypertension. Am J Physiol Regul Integr Comp Physiol.
287:R943–R949. 2004.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Rüster C and Wolf G: The role of the
renin-angiotensin-aldosterone system in obesity-related renal
diseases. Semin Nephrol. 33:44–53. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Papacocea T, Buraga I, Papacocea R,
Badarau AI, Buraga M, Ciornei C, Mihai G, Stoian I and Adam D:
Antioxidant enzymes-potential targets in intracerebral haemorrhage.
Farmacia. 62(1118)2014.
|
|
63
|
Olariu L, Dumitriu B, Craciun L, Buse E,
Rosoiu N, Bojinca M and Papacocea T: The in vitro influence of a
pharmaceutically active small sea fish extract on apoptosis and
proliferation mechanisms amplified by inflammatory conditions.
Farmacia. 66:524–529. 2018.
|
|
64
|
Gómez-Hernández A, Beneit N,
Díaz-Castroverde S and Escribano Ó: Differential role of adipose
tissues in obesity and related metabolic and vascular
complications. Int J Endocrinol. 2016(1216783)2016.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Le Jemtel TH, Samson R, Milligan G,
Jaiswal A and Oparil S: Visceral adipose tissue accumulation and
residual cardiovascular risk. Curr Hypertens Rep.
20(77)2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Shinar S, Berger H, De Souza LR and Ray
JG: Difference in visceral adipose tissue in pregnancy and
postpartum and related changes in maternal insulin resistance. J
Ultrasound Med. 38:667–673. 2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Reijrink M, de Boer SA, Spoor DS, Lefrandt
JD, Lambers Heerspink HJ, Boellaard R, Greuter MJ, Borra RJ,
Hillebrands JL, Slart RH and Mulder DJ: Visceral adipose tissue
volume is associated with premature atherosclerosis in early type 2
diabetes mellitus independent of traditional risk factors.
Atherosclerosis. 290:87–93. 2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Papacocea IR, Badarau IA, Ciornei MC,
Burciulescu SL and Papacocea MT: The effects of caffeine intake on
cardiovascular parameters in sleep deprived medical residents. Rev
Chim Buchar. 70:1445–1448. 2019.
|
|
69
|
Rhee CM, Ahmadi SF and Kalantar-Zadeh K:
The dual roles of obesity in chronic kidney disease: A review of
the current literature. Curr Opin Nephrol Hypertens. 25:208–216.
2016.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Unger RH, Scherer PE and Holland WL:
Dichotomous roles of leptin and adiponectin as enforcers against
lipotoxicity during feast and famine. Mol Biol Cell. 24:3011–3015.
2013.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Kadowaki T, Yamauchi T, Kubota N, Hara K,
Ueki K and Tobe K: Adiponectin and adiponectin receptors in insulin
resistance, diabetes, and the metabolic syndrome. J Clin Invest.
116:1784–1792. 2006.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Slee AD: Exploring metabolic dysfunction
in chronic kidney disease. Nutr Metab (Lond). 9(36)2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Run H and Dong LQ: Adiponectin signaling
and function in insulin target tissues. J Mol Cell Bio. 8:101–109.
2016.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Kuo IC, Wu PH, Lin HY, Niu SW, Huang JC,
Hung CC, Chiu YW and Chen HC: The association of adiponectin with
metabolic syndrome and clinical outcome in patients with
non-diabetic chronic kidney disease. PLoS One.
14(e0220158)2019.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Coimbra S, Reis F, Nunes S, Viana S,
Valente MJ, Rocha S, Catarino C, Rocha-Pereira P, Bronze-da-Rocha
E, Sameiro-Faria M, et al: The protective role of adiponectin for
lipoproteins in end-stage renal disease patients: Relationship with
diabetes and body mass index. Oxid Med Cell Longev.
2019(3021785)2019.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Yaturu S, Reddy RD, Rains J and Jain SK:
Plasma and urine levels of resistin and adiponectin in chronic
kidney disease. Cytokine. 37:1–5. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Papacocea T, Papacocea R, Rădoi M, Pițuru
S and Balan DG: Stomach ‘tastes’ the food and adjusts its emptying:
A neurophysiological hypothesis (Review). Exp Ther Med.
20:2392–2395. 2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Choi HM, Doss HM and Kim KS: Multifaceted
physiological roles of adiponectin in inflammation and diseases.
Int J Mol Sci. 21(1219)2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Briffa JF, McAinch AJ, Poronnik P and
Hryciw DH: Adipokines as a link between obesity and chronic kidney
disease. Am J Physiol Renal Physiol. 305:F1629–F1636.
2013.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tesauro M, Mascali A, Franzese O, Cipriani
S, Cardillo C and Di Daniele N: Chronic kidney disease, obesity,
and hypertension: The role of leptin and adiponectin. Int J
Hyperten. 2012(943605)2012.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Shankar A, Syamala S, Xiao J and Muntner
P: Relationship between plasma leptin level and chronic kidney
disease. Int J Nephrol. 2012(269532)2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Nasrallah MP and Ziyadeh FN: Overview of
the physiology and pathophysiology of leptin with special emphasis
on its role in the kidney. Semin Nephrol. 33:54–65. 2013.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Han DC, Isono M, Chen S, Casaretto C, Hong
SW, Wolf G and Ziyadeh FN: Leptin stimulates type I collagen
production in db/db mesangial cells: Glucose uptakeand TGF-beta
type II receptor expression. Kidney Int. 59:1315–1323.
2001.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Mao S, Fang L, Liu F, Jiang S, Wu L and
Zhang J: Leptin and chronic kidney diseases. J Recept Signal
Transduct Res. 38:89–94. 2018.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Canpolat N, Sever L, Agbas A, Tasdemir M,
Oruc C, Ekmekci OB and Caliskan S: Leptin and ghrelin in chronic
kidney disease: Their associations with protein-energy wasting.
Pediatr Nephrol. 33:2113–2122. 2018.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Noor S, Alam F, Fatima SS, Khan M and
Rehman R: Role of leptin and dyslipidemia in chronic kidney
disease. Pak J Pharm Sci. 31:893–897. 2018.PubMed/NCBI
|
|
87
|
Sharma K, Ramachandrarao S, Qiu G, Usui
HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, et al:
Adiponectin regulates albuminuria and podocyte function in mice. J
Clin Invest. 118:1645–1656. 2008.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Lee MP, Orlov D and Sweeney G: Leptin
induces rat glomerular mesangial cell hypertrophy, but does not
regulate hyperplasia or apoptosis. Int J Obes (Lond). 29:1395–1401.
2005.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Galletti F, D'Elia L, Barba G, Siani A,
Cappuccio FP, Farinaro E, Iacone R, Russo O, De Palma D, Ippolito R
and Strazzullo P: High-circulating leptin levels are associated
with greater risk of hypertension in men independently of body mass
and insulin resistance: Results of an eight-year follow-up study. J
Clin Endocrinol Metab. 93:3922–3926. 2008.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Lu JW, Chi PJ, Lin YL, Wang CH and Hsu BG:
Serum leptin levels are positively associated with aortic stiffness
in patients with chronic kidney disease stage 3-5. Adipocyte.
9:206–211. 2010.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Korczyńska J, Czumaj A, Chmielewski M,
Śledziński M, Mika A and Śledziński T: Increased expression of the
leptin gene in adipose tissue of patients with chronic kidney
disease-the possible role of an abnormal serum fatty acid profile.
Metabolites. 10(98)2020.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Silva Junior and Matos SMA: Padrões
alimentares e doença renal crônica. In Cruz J, Cruz HMM, Kirsztajn
GM, Oliveira RB, Barros RT, eds. Atualidades em Nefrologia 14. São
Paulo: Sarvier, 2016.
|
